Therapeutic Misperceptions in Early‐Phase Cancer Trials: From Categorical to Continuous

&
IRB: Ethics & Human Research 40 (4):13-20 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1002/eahr.404003

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,168

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Phase I Cancer Trials: Therapeutic Research?E. Kodish - 2001 - Hastings Center Report 31 (1):4.
The Risk-Escalation Model: A Principled Design Strategy for Early-Phase Trials.Spencer Phillips Hey & Jonathan Kimmelman - 2014 - Kennedy Institute of Ethics Journal 24 (2):121-139.
An intervention to improve cancer patients' understanding of early-phase clinical trials.Nancy E. Kass, Jeremy Sugarman, Amy M. Medley, Linda A. Fogarty, Holly A. Taylor, Christopher K. Daugherty, Mark R. Emerson, Steven N. Goodman, Fay J. Hlubocky & Herbert I. Hurwitz - 2009 - IRB: Ethics & Human Research 31 (3):1.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2012 - Bioethics 28 (3):138-146.
Phase I cancer trials: Therapeutic research?-Matthew Miller replies.M. Miller - 2001 - Hastings Center Report 31 (1):5-5.
Two concepts of therapeutic optimism.L. A. Jansen - 2011 - Journal of Medical Ethics 37 (9):563-566.
A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial.Alexander Masters & Dominic Nutt - 2017 - Journal of Medical Ethics 43 (11):730-736.
Unrealistic optimism and the ethics of phase I cancer research.Joshua Crites & Eric Kodish - 2013 - Journal of Medical Ethics 39 (6):403-406.
Therapeutic Misconception in Early Phase Trials: Relation is the Cure.Sabina Gainotti & Carlo Petrini - 2011 - Journal of Clinical Research and Bioethics 2 (3).
Evaluating the Risks and Benefits of Phase II and III Clinical Cancer Trials: A Look at Institutional Review Board Members in the Netherlands.H. van Luijn, A. Musschenga, R. Keus & N. Aaronson - 2007 - IRB: Ethics & Human Research 29 (1).
The fiduciary obligation of the physician-researcher in phase IV trials.Rosemarie Dlc Bernabe, Ghislaine Jmw van Thiel, Jan Am Raaijmakers & Johannes Jm van Delden - 2014 - BMC Medical Ethics 15 (1):11.
Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation.Jodi Halpern, David Paolo & Andrew Huang - 2019 - Journal of Medical Ethics 45 (6):384-387.
Selected Issues Related to the Conduct, Reporting, and Analysis of Phase I Trials.Marcelle Denise Winget - 1996 - Dissertation, The Johns Hopkins University
Evidence‐Based Medicine Can’t Be….Adam La Caze - 2008 - Social Epistemology 22 (4):353 – 370.
Phase 1 oncology trials and informed consent.Franklin G. Miller & Steven Joffe - 2013 - Journal of Medical Ethics 39 (12):761-764.

Analytics

Added to PP
2021-04-28

Downloads
9 (#1,257,418)

6 months
4 (#796,773)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Agency and authenticity: Which value grounds patient choice?Daniel Brudney & John Lantos - 2011 - Theoretical Medicine and Bioethics 32 (4):217-227.

View all 11 references / Add more references